NZX 50 Hits 2-Week High on Healthcare Boost

2026-05-25 22:50 By Chusnul Chotimah 1 min. read

The NZX 50 rose 191 points, or 1.5%, to 13,161 in Tuesday morning trade, halting losses from the previous session and hitting its highest level since May 11, mainly boosted by healthcare stocks, energy, and real estate.

Healthcare stocks jumped 5.6%, with Fisher & Paykel Healthcare, a heavyweight stock, surging 9.9% after posting a 24% increase in net profit for the 12 months ended March.

Meanwhile, Ryman Healthcare soared 3.7%.

Easing oil prices, buoyed by optimism over US-Iran talks to end the war, also lifted sentiment after US President Donald Trump said the talks were proceeding nicely.

However, traders remained cautious ahead of the Reserve Bank of New Zealand’s monetary policy decision on Wednesday, with markets expecting the central bank to keep interest rates unchanged while anticipating the release of the government’s 2026 budget.

Other early gainers included Chorus Limited (1.3%), Contact Energy (1.0%), Ebos Group (0.8%), and A2 Milk Company (0.7%).



News Stream
NZX 50 Hits 2-Week High on Healthcare Boost
The NZX 50 rose 191 points, or 1.5%, to 13,161 in Tuesday morning trade, halting losses from the previous session and hitting its highest level since May 11, mainly boosted by healthcare stocks, energy, and real estate. Healthcare stocks jumped 5.6%, with Fisher & Paykel Healthcare, a heavyweight stock, surging 9.9% after posting a 24% increase in net profit for the 12 months ended March. Meanwhile, Ryman Healthcare soared 3.7%. Easing oil prices, buoyed by optimism over US-Iran talks to end the war, also lifted sentiment after US President Donald Trump said the talks were proceeding nicely. However, traders remained cautious ahead of the Reserve Bank of New Zealand’s monetary policy decision on Wednesday, with markets expecting the central bank to keep interest rates unchanged while anticipating the release of the government’s 2026 budget. Other early gainers included Chorus Limited (1.3%), Contact Energy (1.0%), Ebos Group (0.8%), and A2 Milk Company (0.7%).
2026-05-25
NZX 50 Ends 0.2% Lower After Reversing Early Gains
The NZX 50 fell 21 points, or 0.2%, to close at 12,970 on Monday, erasing gains from the previous two sessions and reversing morning strength, mainly weighed down by the energy, tech, consumer staples, real estate, and healthcare sectors. The broader index pulled back from its highest level since May 14, touched on Friday, as traders remained cautious ahead of the RBNZ’s monetary policy decision on Wednesday, with markets expecting the central bank to keep interest rates unchanged. Caution was also built as traders anticipated the release of the government’s 2026 budget later this week. However, gains in US futures capped the decline amid hopes of a US-Iran deal to end the war. Among the top losers were Gentrack Group (-7.3%), Channel Infrastructure (-2.7%), Summerset Group (-2.2%), Westpac Banking Corp. (-1.6%), A2 Milk (-1.6%), Hallenstein Glasson (-1.5%), and Fisher & Paykel (-1.3%).
2026-05-25
New Zealand Shares Rise to Start the Week
The NZX 50 climbed 42 points, or 0.3%, to 13,033 in Monday morning trade, gaining for a third straight session and hitting its highest level since May 13, tracking gains on US futures amid hopes of a US-Iran deal to end the war. Positive data last week continued to lift sentiment after New Zealand’s retail sales grew more than expected in Q1 and the trade surplus reached a record high, with exports increasing to an all-time high. However, traders remained focused on the RBNZ’s monetary policy decision later this week, with markets expecting the central bank to keep interest rates unchanged while anticipating the release of the government’s 2026 budget. Healthcare, consumer staples, and energy stocks mainly drove the index, with notable gains from South Port NZ (1.9%), Infratil (1.1%), A2 Milk (1.0%), Summerset Group (1.1%), Fisher & Paykel (0.9%), and Mainfreight (0.6%).
2026-05-24